Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States
about
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesThe role of HPV in head and neck cancer and review of the HPV vaccineCosts and effectiveness of neonatal male circumcisionAnti-cancer vaccines - a one-hit wonder?Clinical features and treatment strategy for HPV-related oropharyngeal cancer.Analysis of longitudinal multivariate outcome data from couples cohort studies: application to HPV transmission dynamics.Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trialsThe prophylactic role for the human papillomavirus quadrivalent vaccine in males.Association of human papillomavirus-related knowledge, attitudes, and beliefs with HIV status: a national study of gay men.Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study.Evaluation and Management of Anal Intraepithelial Neoplasia in HIV-Negative and HIV-Positive Men Who Have Sex with MenIs expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program.Human papillomavirus-related disease in men: not just a women's issueComparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden.Individualized cost-effectiveness analysis.Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds?Lessons from Australia: human papillomavirus is not a major risk factor for esophageal squamous cell carcinoma.An updated natural history model of cervical cancer: derivation of model parameters.Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical modelsAcceptability and correlates of primary and secondary prevention of cervical cancer among medical students in southwest China: implications for cancer education.Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North AmericaTowards the eradication of HPV infection through universal specific vaccination.Human papillomavirus vaccination for boysRevisiting the cost-effectiveness of universal HPV-vaccination in Denmark accounting for all potentially vaccine preventable HPV-related diseases in males and females.Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys.Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in Norway.Evaluating Cost-effectiveness of Interventions That Affect Fertility and Childbearing: How Health Effects Are Measured Matters.Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesisImpact of coverage-dependent marginal costs on optimal HPV vaccination strategies.Vaccination of boys or catch-up of girls above 11 years of age with the HPV-16/18 AS04-adjuvanted vaccine: where is the greatest benefit for cervical cancer prevention in Italy?Impact of HPV Vaccine Availability on Uptake.Genital warts: a comprehensive reviewQuadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine: for the prevention of genital warts in males.Systematic review of cost-effectiveness analyses for combinations of prevention strategies against human papillomavirus (HPV) infection: a general trend.Human Papillomavirus Vaccination Among Adults and Children in 5 US States.Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine for the prevention of genital warts in males: profile report. demail@springer.com.Quality of life valuations of HPV-associated cancer health states by the general population.How university students view human papillomavirus (HPV) vaccination: A cross-sectional study in Jinan, China.HPV vaccine acceptability in HIV-infected and HIV negative men who have sex with men (MSM) in Ireland.
P2860
Q22306233-F2065E24-0860-4B5A-A913-866271D4B218Q24630128-ADD19EC9-2F42-41AF-8AD5-11F3ADCC3409Q24630822-4D55000C-5ABB-4279-A610-C349D74B44CEQ26995164-5FF48393-4AA1-4381-A09C-12AD5571B7C7Q30249150-A8D7E52E-71D8-4E48-B87C-B6DF67EFE221Q30981780-4D2DB364-A9A5-41A3-831F-8171F74250C2Q31036080-74889F2E-C2F2-4019-BF92-EE5AC141C078Q33158795-AD2920FF-E4F4-416B-AAA2-4D4E241F7CA3Q33624552-1B7A720E-DCBA-436B-B54A-EBE098E5CC6BQ33692293-646EA074-2E0A-4963-B901-1768F5653F07Q33814136-BB071054-2F89-45A2-916E-2A19685B3555Q33848793-69AF9117-F3BD-420B-A627-27769AE1A58DQ33855416-1A98B9C0-28D2-452D-A401-B6A40D407A88Q33934529-AA10BFFA-1A62-4C1B-959F-5FA4D1497AF4Q33963712-7930B793-6187-4452-BA3E-36602D216DAEQ34011808-943FF783-BC83-4719-9EF6-3EC5CC524797Q34029941-07D6E858-0F9B-435C-8EF0-C6F9F9221EDDQ34064235-AD9CE198-8DEB-4E13-B15B-D313A4A74E79Q34083083-9898D98B-3BF3-46B6-9780-F61B06D64A2CQ34113476-52270A89-27D4-4A58-ABC6-016D66C6E010Q34434281-F314B0C4-C816-4E2F-A524-B4A99DEAAD2AQ34635523-13E4B231-AEB8-4CC9-A0C2-8BAE501B6DB9Q34812959-A3FC5467-D9D2-4233-BA22-2992F2E7D175Q34994792-3767113D-DBEB-4A54-986E-17C28B6B3E13Q35092114-1D6E9130-339F-4FBD-A8AB-5B83618CD126Q35126586-93C732AE-3603-45EA-997E-C43975CA8BA8Q35127307-B54DDA59-F930-4390-B4AB-E768A3E8F666Q35564876-0F59E34E-24A2-49A3-999F-041AF7320D16Q35596183-5ED377C6-C504-4072-9320-154308FC2B8CQ35612736-8746A282-54E4-4F31-A3AE-44CC02ECF848Q35779425-F7B51AC4-46EE-4219-95C9-94FB687D35FFQ35787375-F89D6985-D423-479E-ADE8-10B11C6089C5Q36077814-7BDA2D82-5209-4F35-A854-F1E58B12059FQ36270681-D9DEC8A5-CE7E-487D-9ADB-E508D1D89790Q36325832-75915705-91E5-4F1A-BE78-413D362A3680Q36338783-58DCBDAC-2EB5-43C1-B536-5E5AF5F5B574Q36649321-0C500226-45A2-4801-97FF-7A0DFF05BE14Q36678377-D840395A-152C-457C-8652-ADB39220469AQ37130154-5964F72E-05E1-4729-9393-788E3D495B64Q37135212-25E5BE95-2C4C-415B-AAC9-3A40F595FAFD
P2860
Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cost effectiveness analysis of ...... programme in the United States
@ast
Cost effectiveness analysis of ...... programme in the United States
@en
Cost effectiveness analysis of ...... programme in the United States
@nl
type
label
Cost effectiveness analysis of ...... programme in the United States
@ast
Cost effectiveness analysis of ...... programme in the United States
@en
Cost effectiveness analysis of ...... programme in the United States
@nl
prefLabel
Cost effectiveness analysis of ...... programme in the United States
@ast
Cost effectiveness analysis of ...... programme in the United States
@en
Cost effectiveness analysis of ...... programme in the United States
@nl
P2860
P356
P1433
P1476
Cost effectiveness analysis of ...... programme in the United States
@en
P2093
Jane J Kim
P2860
P356
10.1136/BMJ.B3884
P407
P433
P50
P577
2009-01-01T00:00:00Z